James Investment Research Has Increased Its Gilead Sciences (GILD) Position; Silver Point Capital LP Trimmed By $78.00 Million Its Ally Finl (ALLY) Stake

May 22, 2018 - By wolcottdaily

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

James Investment Research Inc increased Gilead Sciences Inc (GILD) stake by 23.25% reported in 2017Q4 SEC filing. James Investment Research Inc acquired 7,644 shares as Gilead Sciences Inc (GILD)’s stock rose 1.93%. The James Investment Research Inc holds 40,524 shares with $2.90 million value, up from 32,880 last quarter. Gilead Sciences Inc now has $87.94B valuation. The stock decreased 0.57% or $0.39 during the last trading session, reaching $67.63. About 5.00M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 22, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Silver Point Capital Lp decreased Ally Finl Inc (ALLY) stake by 91.18% reported in 2017Q4 SEC filing. Silver Point Capital Lp sold 2.69 million shares as Ally Finl Inc (ALLY)’s stock declined 10.36%. The Silver Point Capital Lp holds 260,254 shares with $7.59 million value, down from 2.95 million last quarter. Ally Finl Inc now has $11.65B valuation. The stock increased 0.59% or $0.16 during the last trading session, reaching $27.1. About 1.36M shares traded. Ally Financial Inc. (NYSE:ALLY) has risen 34.39% since May 22, 2017 and is uptrending. It has outperformed by 22.84% the S&P500.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Foster Motley Inc has 0.1% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 8,471 shares. The United Kingdom-based Gsa Capital Prtn Llp has invested 0.44% in Gilead Sciences, Inc. (NASDAQ:GILD). Capital Management Corp Va reported 116,872 shares. Lyons Wealth Management Ltd Liability Co accumulated 10,504 shares. Augustine Asset Mngmt holds 1.8% or 44,348 shares in its portfolio. Legg Mason Asset Management (Japan) Ltd owns 0.24% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 5,600 shares. Windward Cap Company Ca reported 40,543 shares or 0.43% of all its holdings. Price T Rowe Associate Md invested 0.2% in Gilead Sciences, Inc. (NASDAQ:GILD). Rampart Investment Mngmt Co Ltd Com reported 16,016 shares stake. Mawer Limited has 0.4% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Toth Financial Advisory has 0% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 137 shares. State Of New Jersey Common Pension Fund D reported 1.57M shares. Legal And General Gru Plc stated it has 0.36% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Lingohr Partner Asset Gmbh holds 20,573 shares or 0.78% of its portfolio. Quantitative Systematic Strategies Ltd has 0.12% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 6,350 shares.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead: Where’s The Next Catalyst?” on May 18, 2018, also Nasdaq.com with their article: “3 Biotechs on the FDA’s Naughty List That Should Be on Investors’ Buy Lists” published on May 22, 2018, Bizjournals.com published: “Gilead, BioMarin among Bay Area drug makers shamed by FDA in generics ‘gaming’ list” on May 17, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: 247Wallst.com and their article: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” published on May 02, 2018 as well as Seekingalpha.com‘s news article titled: “Gilead Sciences (GILD) Presents at Bank of America Merrill Lynch 2018 Healthcare Conference (Transcript)” with publication date: May 16, 2018.

Since January 2, 2018, it had 0 insider purchases, and 22 sales for $44.80 million activity. 30,000 shares were sold by Alton Gregg H, worth $2.37M. The insider Cogan John Francis sold 5,833 shares worth $434,384. 50,000 shares were sold by MARTIN JOHN C, worth $4.18M. 100,000 shares valued at $8.02M were sold by Meyers James R on Tuesday, January 16. Washington Robin L sold $401,566 worth of stock or 5,000 shares. Another trade for 60,000 shares valued at $4.68 million was sold by WILSON GAYLE E.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Wednesday, February 3 by Standpoint Research. On Thursday, July 27 the stock rating was maintained by Maxim Group with “Hold”. The firm has “Hold” rating given on Wednesday, January 3 by Credit Suisse. UBS maintained the stock with “Buy” rating in Friday, April 29 report. The rating was maintained by Jefferies with “Hold” on Friday, October 27. As per Wednesday, May 2, the company rating was maintained by RBC Capital Markets. Oppenheimer maintained Gilead Sciences, Inc. (NASDAQ:GILD) rating on Wednesday, July 29. Oppenheimer has “Outperform” rating and $120 target. The firm earned “Buy” rating on Friday, April 29 by Citigroup. The stock has “Buy” rating by Jefferies on Tuesday, September 6. The firm has “Hold” rating given on Tuesday, September 5 by Credit Suisse.

James Investment Research Inc decreased Southwest Airlines Co (NYSE:LUV) stake by 303,982 shares to 247,418 valued at $16.19 million in 2017Q4. It also reduced Amkor Technology Inc (NASDAQ:AMKR) stake by 143,380 shares and now owns 163,905 shares. Vonage Holdings Corp (NYSE:VG) was reduced too.

More important recent Ally Financial Inc. (NYSE:ALLY) news were published by: Seekingalpha.com which released: “House votes on bill easing Dodd-Frank” on May 22, 2018, also Seekingalpha.com published article titled: “Congress slaps down CFPB’s auto lending guidance”, Seekingalpha.com published: “Ally Financial (ALLY) Q1 2018 Results – Earnings Call Transcript” on April 26, 2018. More interesting news about Ally Financial Inc. (NYSE:ALLY) was released by: Prnewswire.com and their article: “Ally Encourages Consumers to Save Their Savings with New Campaign” with publication date: May 16, 2018.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>